Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06351085 · ClinicalTrials.gov registry record · NA
Enhancing Lung Cancer Screening Through Human-Centered Intervention
A NA study of Lung Cancer, sponsored by University of California, Davis.
- Recruiting
- Registry status
- NA
- Development phase
- 2,869
- Enrollment target
- 1
- Study location
NCT06351085: Recruiting NA study of Lung Cancer, sponsored by University of California, Davis.
NCT06351085 is a NA study of Lung Cancer that is actively recruiting participants, run by University of California, Davis. The registered enrollment target is 2,869 participants, above the 929-participant average among 409 other Lung Cancer trials with a reported enrollment target (209% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06351085, a NA study of Lung Cancer, is actively recruiting participants, sponsored by University of California, Davis.
- RECRUITING
- Registry status
- NA
- Development phase
- 2,869 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to further understand the factors involved in increasing lung cancer screening.
Primary Outcome
The primary outcome is the proportion of patients aged 50-80 with a history of smoking who receive Lung Cancer Screening during the study period; this outcome will be measured in both intervention groups and the control group.
Conditions Studied
Interventions
- BEHAVIORAL Pre-Visit Planner
- BEHAVIORAL Pre-Visit Planner + MyChart
Study Locations (1)
California
- University of California, Davis - Sacramento
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,869 participants |
| Start Date | 2022-11-10 |
| Est. Completion | 2025-04-14 |
| Phase | NA |
What NCT06351085 shows while recruiting
NCT06351085 is an interventional study that assigns participants to a tested intervention. Its 2,869 participants enrollment target places it among the larger protocols in the corpus, above the 929-participant average among 409 other Lung Cancer trials with a reported enrollment target (209% higher).
The record links to 1 condition, with Lung Cancer appearing as the primary indexed condition, and to 2 interventions - of which Pre-Visit Planner is the first listed.
NCT06351085 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06351085 about?
NCT06351085 is a clinical study titled "Enhancing Lung Cancer Screening Through Human-Centered Intervention". The purpose of this study is to further understand the factors involved in increasing lung cancer screening.
What is the current status of trial NCT06351085?
This trial is currently recruiting. It is a NA study. The enrollment target is 2,869 participants. The study started on 2022-11-10. Estimated completion is 2025-04-14.
What conditions does trial NCT06351085 study?
This clinical trial studies the following conditions: Lung Cancer.
What interventions are being tested in trial NCT06351085?
The interventions under investigation include: Pre-Visit Planner (BEHAVIORAL), Pre-Visit Planner + MyChart (BEHAVIORAL).
Who is sponsoring clinical trial NCT06351085?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06351085 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06351085's enrollment target sits among peer trials
2,869 21st of 409 higher than 389 of 409 other Lung Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Lung Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Lung B.A.S.E.S. 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Ages 40-54
RECRUITING · NA
-
Lung Cancer Screening in High-risk Black Individuals
RECRUITING · NA
-
A Patient and Provider Intervention to Address Health Disparities in Lung Cancer Screening
RECRUITING · NA
-
Exercise as Maintenance Therapy in Advanced Lung Cancer
RECRUITING · NA
-
Improving Care for Rural Patients With Solid Tumors
RECRUITING · NA
-
Stereotactic Magnetic Resonance Guided Radiation Therapy
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05624450 · 2,870 participants · Phase 3
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
- NCT06273436 · 2,894 participants · NA
Healing, Equity, Advocacy and Respect for Mamas
- NCT06150781 · 2,842 participants
Aimovig Pregnancy Exposure Registry
- NCT05564377 · 2,900 participants · Phase 2
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI